Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
A new year, a fresh outlook for beaten-up biotech companies? There are some hopes that conditions will improve during 2023, though few are expecting a dramatic recovery. View the webinar for expert views on the year ahead, and a look at the challenges and opportunities that will present themselves.
Get insights on:
For the full data you can download the 2023 Preview report